These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35717601)

  • 1. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: what are the barriers to implementation in the 'real world'?
    Boriani G; Vitolo M; Leyva F
    Eur J Heart Fail; 2022 Jul; 24(7):1223-1226. PubMed ID: 35717601
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary prevention implantable cardioverter defibrillators for patients with heart failure.
    Beggs SAS; Wright GA; Gardner RS
    Heart; 2023 Dec; 110(1):65-73. PubMed ID: 37463731
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary prevention implantable cardioverter-defibrillators: they work in the real world, too.
    Lampert R
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):624-5. PubMed ID: 22895600
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in implantable cardioverter-defibrillator therapy: Advancement beyond technology alone.
    Bhakta D; Foreman LD
    Trends Cardiovasc Med; 2015 Oct; 25(7):612-3. PubMed ID: 25776986
    [No Abstract]   [Full Text] [Related]  

  • 6. Prospective observational study of implantable cardioverter-defibrillators in primary prevention of sudden cardiac death: study design and cohort description.
    Cheng A; Dalal D; Butcher B; Norgard S; Zhang Y; Dickfeld T; Eldadah ZA; Ellenbogen KA; Guallar E; Tomaselli GF
    J Am Heart Assoc; 2013 Feb; 2(1):e000083. PubMed ID: 23525420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein biomarkers identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillators: findings from the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD).
    Cheng A; Zhang Y; Blasco-Colmenares E; Dalal D; Butcher B; Norgard S; Eldadah Z; Ellenbogen KA; Dickfeld T; Spragg DD; Marine JE; Guallar E; Tomaselli GF
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1084-91. PubMed ID: 25273351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Implantable cardioverter defibrillators in the prevention of sudden cardiac death].
    Bockeria LA; Neminushchiy NM; Mikhaylichenko SI; Novichkov SA; Achkasov EE
    Ter Arkh; 2017; 89(12):103-109. PubMed ID: 29411768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous implantable cardioverter-defibrillators for the prevention of sudden cardiac death: five‑year single-center experience.
    Kempa M; Budrejko S; Zienciuk-Krajka A; Daniłowicz-Szymanowicz L; Królak T; Opielowska-Nowak B; Kwiatkowska J; Raczak G
    Kardiol Pol; 2020 May; 78(5):447-450. PubMed ID: 32186353
    [No Abstract]   [Full Text] [Related]  

  • 10. Implantable cardioverter-defibrillators: indications and unresolved issues.
    Kedia R; Saeed M
    Tex Heart Inst J; 2012; 39(3):335-41. PubMed ID: 22719141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The editor's roundtable: Implantable cardioverter-defibrillators in primary prevention of sudden cardiac death and disparity-related barriers to implementation.
    Friedewald VE; Fonarow GC; Olshansky B; Yancy CW; Roberts WC
    Am J Cardiol; 2011 Feb; 107(4):583-90. PubMed ID: 21295175
    [No Abstract]   [Full Text] [Related]  

  • 12. Implantable cardioverter-defibrillator therapy in the elderly: the continuing quest for data.
    Barsheshet A; Huang DT
    Cardiol J; 2011; 18(5):473-5. PubMed ID: 21947981
    [No Abstract]   [Full Text] [Related]  

  • 13. Association Between Use of Primary-Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients With Heart Failure: A Prospective Propensity Score-Matched Analysis From the Swedish Heart Failure Registry.
    Schrage B; Uijl A; Benson L; Westermann D; Ståhlberg M; Stolfo D; Dahlström U; Linde C; Braunschweig F; Savarese G
    Circulation; 2019 Nov; 140(19):1530-1539. PubMed ID: 31476893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic implantable cardioverter defibrillators for primary prevention: From implantation to heart transplantation.
    Algalarrondo V; Perault R; Bories MC; Narayanan K; Garcia R; Combes N; Perier MC; Defaye P; Sadoul N; Gras D; Klug D; Bordachar P; Fauchier L; Deharo JC; Leclercq C; Boveda S; Marijon E; Babuty D;
    Arch Cardiovasc Dis; 2018 Dec; 111(12):758-765. PubMed ID: 30078651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electrical treatment in heart failure].
    Leclercq C; Mabo P; Daubert C
    Rev Prat; 2010 Sep; 60(7):947-50. PubMed ID: 21033492
    [No Abstract]   [Full Text] [Related]  

  • 17. Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death in the real world: Main findings from the French multicentre DAI-PP programme (pilot phase).
    Boveda S; Garcia R; Defaye P; Piot O; Narayanan K; Barra S; Gras D; Providencia R; Algalarrondo V; Beganton F; Perier MC; Jacob S; Bordachar P; Babuty D; Klug D; Leclercq C; Fauchier L; Sadoul N; Deharo JC; Marijon E;
    Arch Cardiovasc Dis; 2019; 112(8-9):523-531. PubMed ID: 31471226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: unanswered questions.
    Wang NC; Piccini JP; Gheorghiade M
    Heart Fail Rev; 2011 Sep; 16(5):477-80. PubMed ID: 21424741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous implantable cardioverter defibrillator indication in prevention of sudden cardiac death in difficult clinical situations: A French expert position paper.
    Probst V; Boveda S; Sadoul N; Marquié C; Chauvin M; Mondoly P; Gras D; Jacon P; Defaye P; Leclercq C; Anselme F
    Arch Cardiovasc Dis; 2020 May; 113(5):359-366. PubMed ID: 32334981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
    Ding L; Hua W; Niu H; Chen K; Zhang S
    Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.